Susquehanna International Group’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,100
Closed -$197K 13274
2022
Q2
$197K Hold
11,100
﹤0.01% 10649
2022
Q1
$226K Buy
+11,100
New +$210K ﹤0.01% 10947
2021
Q2
Sell
-35,000
Closed -$830K 12617
2021
Q1
$830K Sell
35,000
-24,200
-41% -$575K ﹤0.01% 8213
2020
Q4
$1.19M Buy
59,200
+33,400
+129% +$652K ﹤0.01% 6317
2020
Q3
$537K Sell
25,800
-1,000
-4% -$18.1K ﹤0.01% 7512
2020
Q2
$469K Sell
26,800
-35,200
-57% -$689K ﹤0.01% 7492
2020
Q1
$1.01M Buy
62,000
+50,500
+439% +$1.04M ﹤0.01% 5372
2019
Q4
$237K Sell
11,500
-10,100
-47% -$168K ﹤0.01% 8453
2019
Q3
$248K Sell
21,600
-10,400
-33% -$119K ﹤0.01% 8689
2019
Q2
$421K Buy
32,000
+19,000
+146% +$254K ﹤0.01% 7628
2019
Q1
$197K Sell
13,000
-5,600
-30% -$89.7K ﹤0.01% 7891
2018
Q4
$319K Sell
18,600
-22,800
-55% -$390K ﹤0.01% 6880
2018
Q3
$610K Buy
41,400
+1,000
+2% +$17.7K ﹤0.01% 6167
2018
Q2
$964K Buy
40,400
+17,900
+80% +$440K ﹤0.01% 5428
2018
Q1
$575K Sell
22,500
-16,600
-42% -$396K ﹤0.01% 6352
2017
Q4
$722K Buy
39,100
+15,800
+68% +$226K ﹤0.01% 5884
2017
Q3
$244K Buy
23,300
+10,100
+77% +$111K ﹤0.01% 7719
2017
Q2
$165K Buy
+13,200
New +$130K ﹤0.01% 8438

Other funds holding COLL

Susquehanna International Group's COLL Position: Q1 2026 in Review

Susquehanna International Group increased its Collegium Pharmaceutical (COLL) stake by 274% in Q1 2026, buying an estimated $780K and bringing the position to 25,157 shares worth $832K. The position accounts for ﹤0.01% of the portfolio, ranked #8382.

Susquehanna International Group first reported a position in COLL in Q3 2015 and has held it in 25 quarters since. The position peaked at $1.87M in Q2 2018. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Susquehanna International Group held 25,157 shares of Collegium Pharmaceutical worth $832K as of Q1 2026.
  • Susquehanna International Group bought 18,430 Collegium Pharmaceutical shares in Q1 2026, an estimated $780K.
  • Collegium Pharmaceutical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8382 holding.
  • Susquehanna International Group first reported a position in Collegium Pharmaceutical in Q3 2015 and has held it in 25 quarters since.
  • Susquehanna International Group's Collegium Pharmaceutical position peaked at $1.87M in Q2 2018.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.